Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
38
|
|
0.030 |
None |
1.000 |
3 |
|
1990 |
2006 |
Jaw Keratocyst
|
disease |
Neoplasms; Musculoskeletal Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
51
|
4
|
0.030 |
None |
1.000 |
3 |
|
1993 |
2019 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.020 |
None |
1.000 |
2 |
|
1993 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Pneumonia, Bacterial
|
group |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
66
|
2
|
0.200 |
None |
1.000 |
1 |
|
1995 |
1995 |
Nephrosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
68
|
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.971 |
70 |
2
|
1999 |
2020 |
Kaposi Sarcoma
|
disease |
Neoplasms; Infections
|
Neoplastic Process
|
488
|
15
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2003 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.980 |
49 |
|
2000 |
2020 |
Cryptosporidiosis
|
disease |
Digestive System Diseases; Infections; Animal Diseases
|
Disease or Syndrome
|
40
|
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Respiratory Distress Syndrome, Adult
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
434
|
60
|
0.210 |
None |
1.000 |
2 |
|
2002 |
2017 |
Oligohydramnios
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
129
|
21
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
55 |
|
2003 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
53 |
|
2003 |
2020 |
Neoplasms, Vascular Tissue
|
group |
Neoplasms
|
Neoplastic Process
|
67
|
1
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2009 |
Hemangioma
|
disease |
Neoplasms
|
Neoplastic Process
|
256
|
24
|
0.020 |
None |
0.500 |
2 |
|
2003 |
2008 |
Hyperoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Lymphangioma
|
disease |
Neoplasms
|
Neoplastic Process
|
22
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1296
|
609
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Syphilis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
80
|
3
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1768
|
347
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.100 |
None |
1.000 |
25 |
|
2005 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.100 |
None |
1.000 |
18 |
|
2005 |
2018 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2008 |
Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
467
|
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |